Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05020587 · ClinicalTrials.gov registry record · NA
Consulting After Combat: Interviewing Veterans to Develop a Therapy to Restore Functioning and Reintegration After Moral Injury Events
A NA study of Moral Injury and Functional Impairment, sponsored by VA Office of Research and Development.
- Active
- Registry status
- NA
- Development phase
- 12
- Enrollment target
- 1
- Study location
NCT05020587: Active NA study of Moral Injury and Functional Impairment, sponsored by VA Office of Research and Development.
NCT05020587 is a NA study of Moral Injury and Functional Impairment that is active but no longer recruiting, run by VA Office of Research and Development. The registered enrollment target is 12 participants, below the 141-participant average among 7 other Moral Injury trials with a reported enrollment target (91% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05020587, a NA study of Moral Injury and Functional Impairment, is active but no longer recruiting, sponsored by VA Office of Research and Development.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 12 participants
- Enrollment target
- 1
- Study location
Study Summary
Despite the VA's best efforts to treat the psychosocial impact of war, many combat Veterans report lingering difficulty reintegrating into meaningful post-deployment lives. War is among the most extreme forms of human experience but, for many, wartime trauma was treated using models transported from civilian single-incident trauma contexts. Veterans have unique needs and experiences that require culturally responsive and sensitive conceptualizations and treatments. Patient-centered care is improved by providing multiple effective treatment options and this project, if successful, could have a significant impact on VA care. This CDA-2 project has the potential to offer innovative treatment for traumatized combat Veterans who otherwise may not find full relief from PTSD. Clinical research practice will be advanced by employing state-of-the-art user-centered design methods combined with expert clinical feedback to develop an effective and usable group treatment manual that will meet VA needs.
Primary Outcome
The AIM will be descriptively analyzed, and the mean and standard deviation; mean scores \>/ 4 will indicate acceptability.
Conditions Studied
Interventions
- BEHAVIORAL Open pilot trial of a group therapy manual.
Study Locations (1)
Texas
- Central Texas Veterans Health Care System, Temple, TX - Temple
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 12 participants |
| Start Date | 2022-02-01 |
| Est. Completion | 2026-10-30 |
| Phase | NA |
What the registry record for NCT05020587 still lists
NCT05020587 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 12 participants, a relatively small participant target, below the 141-participant average among 7 other Moral Injury trials with a reported enrollment target (91% lower).
The record links to 2 conditions, with Moral Injury appearing as the primary indexed condition, and to 1 intervention - of which Open pilot trial of a group therapy manual. is the first listed.
NCT05020587 reports a single indexed study location in Texas.
Frequently Asked Questions
What is clinical trial NCT05020587 about?
NCT05020587 is a clinical study titled "Consulting After Combat: Interviewing Veterans to Develop a Therapy to Restore Functioning and Reintegration After Moral Injury Events". Despite the VA's best efforts to treat the psychosocial impact of war, many combat Veterans report lingering difficulty reintegrating into meaningful post-deployment lives. War is among the most extreme forms of human experience but, for many, wartime trauma was treated using models transported from...
What is the current status of trial NCT05020587?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 12 participants. The study started on 2022-02-01. Estimated completion is 2026-10-30.
What conditions does trial NCT05020587 study?
This clinical trial studies the following conditions: Moral Injury, Functional Impairment.
What interventions are being tested in trial NCT05020587?
The interventions under investigation include: Open pilot trial of a group therapy manual. (BEHAVIORAL).
Who is sponsoring clinical trial NCT05020587?
This trial is sponsored by VA Office of Research and Development, which has 1,668 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05020587 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Moral Injury
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
General Psychological Distress, PTSD, and Co-Morbidities in Healthcare Workers Consequent to COVID-19
RECRUITING · NA
-
Better Together Physician Coaching to Mitigate Burnout Amongst Clinicians
COMPLETED · NA
-
Pilot Study Testing a Web-Based Moral Elevation Intervention for Veterans With PTSD and Moral Injury
COMPLETED · NA
-
Mindful Self Compassion for Combat Deployed Veterans With Moral Injury and Co-occurring PTSD-SUD
COMPLETED · NA
-
Integrative Bilateral Cervical Sympathetic Blocks for Trauma-Related Symptoms in Special Operations Veterans: A Prospective Case Series
RECRUITING
-
Moral Injury Symptom Scale/Moral Injury Outcome Scale
COMPLETED
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02602769 · 12 participants
Whole Transcriptome Profiling and Metabolic Phenotyping in Children With ROHHAD Syndrome
- NCT02605421 · 12 participants · Phase 2
Myeloablative Consolidation Therapy and Tandem Autologous Stem Cell Rescue in Patients With High-Risk Neuroblastoma
- NCT02619448 · 12 participants · Early Phase 1
Concurrent Chemotherapy Plus HFR Radiation Therapy in Inoperable NSCLC
- NCT03311503 · 12 participants · Phase 1
Phase I/II Trial of Lentiviral Gene Transfer for SCID-X1 With Low Dose Targeted Busulfan Conditioning
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI